4EMA. Committee for Medicinal Products for Veterinary Use ( EMA/ CVMP/91406/2011 ) [ DB/OL]. http ://www. ema. europa, eu/docs/ en GB/document_library/Summary_of opinion_ - _Initial_authori - sation/ veterinary/0O2009/ WC500103295. pdf.
5Lekeux P. Bovine respiratory disease complex: a European perspective [J]. Bovine Practitioner, 1995,29:71 - 75.
6Cusack P M. Effect of mass medication with antibiotics at feedlot entry on the health and growth rate of cattle destined for the Australian domestic market[ J]. Australian Veterinary Journal,2004, 82:154 - 156.
7Duff G C, Galyean M L. Board - invited review: recent advances in management of highly stressed, newly received feedlot cattle [ J ]. Journal of Animal Science,2007,85:823 -840.
8Gay E, Barnouin J. A nation - wide epidemiological study of acute bovine respiratory disease in France [ J ]. Preventive Veterinary Medicine,2009,89:265 - 271.
9Watts J L,Sweeney M T. Antimicmbial resistance in bovine respiratory disease pathogens : measures, trends, and impact on efficacy [ J ]. Vet Clin North Am Food Anim Pract,2010,26:79 -88.
